Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Forms of hereditary angioedema that occur due to mutations in the gene for complement C1 inhibitor protein. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.
Features include always present findings: Peripheral axonal neuropathy, Hypoesthesia, Reduced circulating CH50 activity, and Decreased circulating complement C4 concentration and others; and common findings: Laryngeal edema. 17 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 4 | Diarrhea, Intestinal edema, Vomiting |
SERPING1 function has not been fully characterized.
Hereditary angioedema with C1Inh deficiency is caused by mutations in the SERPING1 gene on chromosome 11.
Genetic testing for SERPING1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hereditary angioedema with C1Inh deficiency has been reported in the published literature.
Phenotype severity distribution: 7 always present features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 1 PHASE3, 1 PHASE2. Research is primarily industry-sponsored.
75 publications have been identified in PubMed for hereditary angioedema with C1Inh deficiency. Research spans Case Report / Case Series (36%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 27 |
Data assembled from 8 of 12 sources · Last updated Sep 20, 2026, 1:01 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Blood and immune system |
1 |
Autoimmunity |
Brain and nerves | 1 | Peripheral axonal neuropathy |
Skin | 1 | Erythema |
Muscles | 1 | Muscle weakness |
Research summaries | 19 | 25% |
Disease patterns and progression | 13 | 17% |
Laboratory research | 5 | 7% |
Other research | 4 | 5% |
Testing and diagnosis research | 3 | 4% |
Clinical study results | 3 | 4% |
New treatment approaches | 1 | 1% |
Guan Z (2026). [PMID: 41560114](https://pubmed.ncbi.nlm.nih.gov/41560114/). *Medicine (Baltimore)*. [Case Report / Case Series]
Tuncay G (2026). [PMID: 41598277](https://pubmed.ncbi.nlm.nih.gov/41598277/). *Life (Basel)*. [Epidemiology / Natural History]
Ariue B (2026). [PMID: 41057108](https://pubmed.ncbi.nlm.nih.gov/41057108/). *Ann Allergy Asthma Immunol*. [Diagnostic / Biomarker]
Hisamoto T (2026). [PMID: 41850960](https://pubmed.ncbi.nlm.nih.gov/41850960/). *J Dermatol Sci*. [Case Report / Case Series]
Zhang B (2026). [PMID: 42125081](https://pubmed.ncbi.nlm.nih.gov/42125081/). *Front Med (Lausanne)*. [Case Report / Case Series]
Habib R (2026). [PMID: 42113672](https://pubmed.ncbi.nlm.nih.gov/42113672/). *J Investig Med High Impact Case Rep*. [Case Report / Case Series]
Rodriguez Espada A (2026). [PMID: 41026970](https://pubmed.ncbi.nlm.nih.gov/41026970/). *Blood Adv*. [Epidemiology / Natural History]
Li X (2026). [PMID: 41578566](https://pubmed.ncbi.nlm.nih.gov/41578566/). *Medicine (Baltimore)*. [Case Report / Case Series]
Kerrigan MJ (2026). [PMID: 30844193](https://pubmed.ncbi.nlm.nih.gov/30844193/). *Unknown Journal*. [Other]
Barešić M (2026). [PMID: 41817288](https://pubmed.ncbi.nlm.nih.gov/41817288/). *Eur Ann Allergy Clin Immunol*. [Epidemiology / Natural History]